255 related articles for article (PubMed ID: 7563210)
21. [Docetaxel in the adjuvant treatment of operable breast carcinoma. News from ASCO 2002].
Montemurro F
Tumori; 2002; 88(4):A1-7. PubMed ID: 12402832
[No Abstract] [Full Text] [Related]
22. Taxane-based therapy for breast cancer: combination or sequential therapy?
Sparano JA; Rajdev L
Cancer Invest; 2000; 18(5):498-500. PubMed ID: 10834036
[No Abstract] [Full Text] [Related]
23. [Role of taxanes in treatment of breast cancer].
Gorbunova VA; Besova NS
Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
[No Abstract] [Full Text] [Related]
24. Paclitaxel plus doxorubicin in metastatic breast Ca: the Milan experience.
Gianni L
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):13-5. PubMed ID: 9516596
[TBL] [Abstract][Full Text] [Related]
25. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
Gogas H; Fountzilas G
Ann Oncol; 2003 May; 14(5):667-74. PubMed ID: 12702519
[No Abstract] [Full Text] [Related]
26. Optimal chemotherapy for women with breast cancer: the plot thickens.
Pater JL; Pritchard KI
J Clin Oncol; 2003 Mar; 21(6):963-4. PubMed ID: 12637457
[No Abstract] [Full Text] [Related]
27. In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.
Grosse PY; Bressolle F; Pinguet F
Eur J Cancer; 1998 Jan; 34(1):168-74. PubMed ID: 9624253
[TBL] [Abstract][Full Text] [Related]
28. [A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy].
Oura S; Tanino H; Yoshimasu T; Sakurai T; Nakamura T; Kokawa Y; Matsuyama K; Naito Y
Gan To Kagaku Ryoho; 2001 Apr; 28(4):511-4. PubMed ID: 11329786
[TBL] [Abstract][Full Text] [Related]
29. Integration of docetaxel into adjuvant breast cancer treatment regimens.
Hortobagyi GN
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):27-33. PubMed ID: 12108895
[TBL] [Abstract][Full Text] [Related]
30. Review of docetaxel/doxorubicin combination in metastatic breast cancer.
DiƩras V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):31-3. PubMed ID: 9364539
[TBL] [Abstract][Full Text] [Related]
31. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.
Ravdin PM
Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455
[TBL] [Abstract][Full Text] [Related]
32. [Docetaxel symposium].
Viens P
Bull Cancer; 1997 Aug; 84(8):833-4. PubMed ID: 9339190
[No Abstract] [Full Text] [Related]
33. [Progress and perspectives in palliative therapy of breast carcinoma].
Verlag GT
Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
[No Abstract] [Full Text] [Related]
34. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial.
Heys SD; Hutcheon AW; Sarkar TK; Ogston KN; Miller ID; Payne S; Smith I; Walker LG; Eremin O;
Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S69-74. PubMed ID: 12435290
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
[TBL] [Abstract][Full Text] [Related]
36. A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.
Lissoni P; Bucovec R; Malugani F; Ardizzoia A; Villa S; Gardani GS; Vaghi M; Tancini G
Anticancer Res; 2002; 22(2B):1131-4. PubMed ID: 12168912
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Valero V; Holmes FA; Walters RS; Theriault RL; Esparza L; Fraschini G; Fonseca GA; Bellet RE; Buzdar AU; Hortobagyi GN
J Clin Oncol; 1995 Dec; 13(12):2886-94. PubMed ID: 8523051
[TBL] [Abstract][Full Text] [Related]
38. Phase III randomized trials of docetaxel in patients with metastatic breast cancer.
Crown J
Semin Oncol; 1999 Jun; 26(3 Suppl 8):33-8. PubMed ID: 10403472
[TBL] [Abstract][Full Text] [Related]
39. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
[TBL] [Abstract][Full Text] [Related]
40. Single-agent docetaxel (Taxotere) in randomized phase III trials.
Burris HA
Semin Oncol; 1999 Jun; 26(3 Suppl 9):1-6. PubMed ID: 10426452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]